Sellas Life Sciences Group Inc (SLS)
Cost of Revenue
$0.00
TTM · Period ending: · USD

SLS Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
SLS TTM Cost of Revenue ($0.00 → $0.00)
TTM cost of revenue
High-resolution chart · PNG
SLS cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 100,000 | |
| 100,000 | |
| 100,000 | |
| 200,000 | |
| 200,000 | |
| 200,000 | |
| 200,000 | |
| 100,000 | |
| 0 | |
| 0 | |
| 100,000 | |
| 200,000 | |
| 300,000 | |
| 300,000 | |
| 200,000 | |
| 100,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 861,000 | |
| 861,000 | |
| 1,329,000 | |
| 1,722,000 | |
| 1,339,000 | |
| 1,586,000 | |
| 1,465,000 | |
| 1,403,000 | |
| 1,144,000 | |
| 1,198,000 | |
| 8,837,000 | |
| 8,506,000 | |
| 8,287,000 | |
| 13,514,000 | |
| 11,211,000 | |
| 16,821,000 | |
| 16,821,000 | |
| 11,293,000 | |
| 5,610,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |